This was sustained over a 12-month follow-up, supporting both enhanced efficacy and safety
Peptide Vials (Tesamorelin, 5 mg each): 8 weeks 23 vials (112 mg total) 12 weeks 34 vials (168 mg total) 16 weeks 45 vials (224 mg total) Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial for reconstitution
Bikkad Department of Biochemistry MIMSR Medical College Latur (Pin code- 413531) Maharashtra India Accepted November 18 2013 Citation: Bikkad MD, Somwanshi SD, Ghuge SH, Nagane NS
[DOI] [PMC free article] [PubMed] [Google Scholar] 31.Awad MM, Oxnard GR, Jackman DM, Savukoski DO, Hall D, Shivdasani P, et al